AstraZeneca PLC (AZN.L) Financials
AZN.L Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2025 | 8.5 trillion | 4.9 trillion |
| Sept. 30, 2025 | 8.5 trillion | 5.1 trillion |
| June 30, 2025 | 8.2 trillion | 4.9 trillion |
| March 30, 2025 | 8.2 trillion | 5.0 trillion |
AZN.L Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2025 | 78.5 billion | ? |
| Sept. 30, 2025 | 330.9 billion | ? |
| June 30, 2025 | 106.6 billion | ? |
| March 30, 2025 | 253.8 billion | ? |
AZN.L Net Income
| Date | Net Income |
|---|---|
| Dec. 31, 2025 | 173.1 billion |
| Sept. 30, 2025 | 188.4 billion |
| June 30, 2025 | 227.8 billion |
| March 30, 2025 | 225.4 billion |
AZN.L Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2025 | - | - | 134.2 billion |
| Sept. 30, 2025 | 608.6 billion | 1.9 trillion | 130.8 billion |
| June 30, 2025 | 518.1 billion | 1.9 trillion | 118.9 billion |
| March 30, 2025 | 418.0 billion | 2.2 trillion | 119.9 billion |
AZN.L Shares Outstanding
AZN.L Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2025 | 95.8 billion | 287.4 billion | 420.1 billion | - |
| Sept. 30, 2025 | 51.0 billion | 272.5 billion | 380.9 billion | 11.0 billion |
| June 30, 2025 | 140.1 billion | 258.4 billion | 299.0 billion | 10.4 billion |
| March 30, 2025 | 33.2 billion | 245.3 billion | 287.2 billion | 10.2 billion |
AZN.L Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2025 | 1.2 trillion | 232.0 billion |
| Sept. 30, 2025 | 1.1 trillion | 212.9 billion |
| June 30, 2025 | 1.1 trillion | 268.4 billion |
| March 30, 2025 | 1.1 trillion | 254.1 billion |
AZN.L
Price: GBp12,300
Dividend Yield: 1.30%
Forward Dividend Yield: 1.29%
Payout Ratio: 4942.68%
Dividend Per Share: 159.00 GBp
Earnings Per Share: 4.88 GBp
P/E Ratio: 30.86
Exchange: LSE
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: United Kingdom
Volume: 1.8 million
Market Capitalization: 186.8 billion
Average Dividend Frequency: 2
Years Paying Dividends: 34
DGR3: 10.97%
DGR5: 9.40%
DGR10: 8.79%
DGR20: 12.97%